<?xml version="1.0" encoding="UTF-8"?>
<html xmlns="http://www.w3.org/1999/xhtml">
 <head charset="UTF-8"/>
 <style> * { font-family : helvetica;} .font18 { font-size : 18; } .font23 { font-size : 23; } .font10 { font-size : 10; } .font11 { font-size : 11; } .font12 { font-size : 12; } .font13 { font-size : 13; } .font30 { font-size : 30; } .font14 { font-size : 14; } .font15 { font-size : 15; }</style>
 <body>
  <p>
   <span class="font30">the </span>
   <span class="font23">and </span>
   <span class="font18">with </span>
   <span class="font15">COVID- </span>
   <span class="font14">patients </span>
   <span class="font14">are </span>
   <span class="font13">that </span>
   <span class="font13">for </span>
   <span class="font13">{background </span>
   <span class="font13">may </span>
   <span class="font13">risk </span>
   <span class="font13">al., </span>
   <span class="font13">et√Ç </span>
   <span class="font12">margin </span>
   <span class="font12">{border-style </span>
   <span class="font12">viral </span>
   <span class="font12">immune </span>
   <span class="font12">infections </span>
   <span class="font12">px;} </span>
   <span class="font12">#ffffff;} </span>
   <span class="font11">multiple </span>
   <span class="font11">have </span>
   <span class="font11">not </span>
   <span class="font11">treatment </span>
   <span class="font11">should </span>
   <span class="font11">The </span>
   <span class="font11">Continue </span>
   <span class="font11">dosing </span>
   <span class="font11">from </span>
   <span class="font11">DMTs </span>
   <span class="font11">associated </span>
   <span class="font11">being </span>
   <span class="font11">during </span>
   <span class="font11">infection </span>
   <span class="font11">lymphocyte </span>
   <span class="font11">natalizumab </span>
   <span class="font11">phase </span>
   <span class="font11">potential </span>
   <span class="font11">such </span>
   <span class="font11">their </span>
   <span class="font11">Very </span>
   <span class="font11">complications </span>
   <span class="font11">coronavirus </span>
   <span class="font11">immunosuppressive </span>
   <span class="font11">other </span>
   <span class="font11">respiratory </span>
   <span class="font11">severe </span>
   <span class="font11">was </span>
   <span class="font10">DMT </span>
   <span class="font10">Engl. </span>
   <span class="font10">Yes, </span>
   <span class="font10">disease </span>
   <span class="font10">high </span>
   <span class="font10">more </span>
   <span class="font10">pandemic </span>
   <span class="font10">px; </span>
   <span class="font10">relatively </span>
   <span class="font10">who </span>
   <span class="font10">{font-family </span>
   <span class="font10">Maintenance </span>
   <span class="font10">cladribine </span>
   <span class="font10">depletion </span>
   <span class="font10">first </span>
   <span class="font10">font-size </span>
   <span class="font10">low </span>
   <span class="font10">prolonged </span>
   <span class="font10">sclerosis </span>
   <span class="font10">shedding. </span>
   <span class="font10">than </span>
   <span class="font10">these </span>
   <span class="font10">they </span>
   <span class="font10">virus </span>
   <span class="font10">Med. </span>
   <span class="font10">Suspend </span>
   <span class="font10">Theoretical </span>
   <span class="font10">These </span>
   <span class="font10">This </span>
   <span class="font10">about </span>
   <span class="font10">but </span>
   <span class="font10">double; </span>
   <span class="font10">fingolimod </span>
   <span class="font10">modulators </span>
   <span class="font10">months </span>
   <span class="font10">one </span>
   <span class="font10">result </span>
   <span class="font10">this </span>
   <span class="font10">treated </span>
   <span class="font10">will </span>
   <span class="font10">Elsevier </span>
   <span class="font10">Moderate </span>
   <span class="font10">Scler. </span>
   <span class="font10">also </span>
   <span class="font10">antiviral </span>
   <span class="font10">any </span>
   <span class="font10">based </span>
   <span class="font10">border-color </span>
   <span class="font10">border-width </span>
   <span class="font10">case </span>
   <span class="font10">cause </span>
   <span class="font10">considered </span>
   <span class="font10">continue </span>
   <span class="font10">depending </span>
   <span class="font10">dose </span>
   <span class="font10">higher </span>
   <span class="font10">human </span>
   <span class="font10">infection. </span>
   <span class="font10">ocrelizumab </span>
   <span class="font10">only </span>
   <span class="font10">our </span>
   <span class="font10">patient </span>
   <span class="font10">recommended </span>
   <span class="font10">reconstitution </span>
   <span class="font10">relapsing </span>
   <span class="font10">response </span>
   <span class="font10">solid; </span>
   <span class="font10">therapies </span>
   <span class="font10">there </span>
   <span class="font10">transplant </span>
   <span class="font10">use </span>
   <span class="font10">were </span>
   <span class="font10">{font-style </span>
   <span class="font10">{font-weight </span>
   <span class="font10">/mm </span>
   <span class="font10">COVID-. </span>
   <span class="font10">Disord. </span>
   <span class="font10">For </span>
   <span class="font10">IRT </span>
   <span class="font10">Probably </span>
   <span class="font10">SARS-CoV- </span>
   <span class="font10">Yes </span>
   <span class="font10">active </span>
   <span class="font10">acute </span>
   <span class="font10">bold </span>
   <span class="font10">cell </span>
   <span class="font10">centre </span>
   <span class="font10">clear </span>
   <span class="font10">continous </span>
   <span class="font10">count </span>
   <span class="font10">counts </span>
   <span class="font10">courier; </span>
   <span class="font10">delay </span>
   <span class="font10">em; </span>
   <span class="font10">health </span>
   <span class="font10">hence </span>
   <span class="font10">immunosuppression </span>
   <span class="font10">increased </span>
   <span class="font10">increases </span>
   <span class="font10">infected </span>
   <span class="font10">infectious </span>
   <span class="font10">intermittent </span>
   <span class="font10">less </span>
   <span class="font10">likely </span>
   <span class="font10">management </span>
   <span class="font10">moderate </span>
   <span class="font10">need </span>
   <span class="font10">neurologists </span>
   <span class="font10">neurotropic </span>
   <span class="font10">novel </span>
   <span class="font10">present </span>
   <span class="font10">problem </span>
   <span class="font10">progressive </span>
   <span class="font10">pt;} </span>
   <span class="font10">public </span>
   <span class="font10">recommendations </span>
   <span class="font10">reduce </span>
   <span class="font10">resource </span>
   <span class="font10">safe </span>
   <span class="font10">sclerosisN. </span>
   <span class="font10">start </span>
   <span class="font10">system </span>
   <span class="font10">time </span>
   <span class="font10">tract </span>
   <span class="font10">which </span>
   <span class="font10">your </span>
  </p>
 </body>
</html>
